BSE filing, NSE: SOMANYCERA. Summary written from the filing by ALFA Finder's alert engine.
Somany Ceramics Ltd: key numbers
- Share price
- ₹543.00
- Market cap
- ₹2,227 Cr
- Revenue (annual)
- ₹2,790 Cr
- Net profit (annual)
- ₹81.19 Cr
- P/E (TTM)
- 20.9×Sector 40.5×
- Promoter holding
- 55.20%+0.00% QoQ
- FII holding
- 2.88%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Somany Ceramics Ltd
All →Somany Ceramics Board Meeting Date
Somany Ceramics scheduled a board meeting on 4 Nov 2026 to consider Q2/H1 results. No other material agenda items are disclosed.
Somany Ceramics Other Announcement
Somany Ceramics Ltd has submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, as per regulatory requirements under Regulation 31(1)(b).
Somany Ceramics Acquisition Worth ₹58.8 Cr
Somany Ceramics extended the timeline for its proposed 49% investment in Siravit Ceramics Private Limited by three months, now expected by 8th January, 2027.
- Value
- ₹58.80 Cr
Somany Ceramics Earnings Call Transcript: Key Takeaways
Somany Ceramics delivered margin improvement despite flat volumes, driven by high capacity utilization and operational efficiencies. Management remains cautious on volume growth while aggressively investing in high-margin value-added segments and South India expansion.
- Call
- Guides 7% growth
Somany Ceramics Annual General Meeting
Somany Ceramics held its 58th Annual General Meeting on August 12, 2026. The meeting concluded after transacting ordinary and special business resolutions.
Somany Ceramics Investor Presentation: Key Takeaways
Somany Ceramics delivered strong Q1FY27 performance with 24% YoY revenue growth and EBITDA margin expansion to 11.6%. Focus remains on product premiumization and Southern market expansion.
Other legal & regulatory announcements
All →SMS Pharmaceuticals Legal & Regulatory
SMS Pharmaceuticals received an Income Tax appellate order under Section 250 dismissing its appeal for AY 2018-19. The company says there is no material impact and is reviewing next steps.
- Value
- ₹0.40 Cr
SMS Pharmaceuticals Legal & Regulatory
SMS Pharmaceuticals disclosed that the CIT(Appeals) dismissed its appeal against a ₹7.19 Crore income tax assessment for AY 2018-19. The company is reviewing the order and expects no material impact.
- Value
- ₹7.19 Cr
SMS Pharmaceuticals Legal & Regulatory
SMS Pharmaceuticals received an Income Tax appellate order allowing its appeal for AY 2023-24. The outstanding tax demand of Rs.45.63 Crore, including interest, stands vacated.
- Value
- ₹45.63 Cr
DPSC Legal & Regulatory
DPSC (India Power Corporation) received NSE and MSE fines for the late FY2026 Annual Report. Total impact is Rs.2.42 lakh; the company plans to seek waiver.
- Value
- ₹0.02 Cr
GSB Finance Legal & Regulatory
Coffers Finvest (formerly GSB Finance) reported SAT disposed of an appeal against one BSE fine, which was withdrawn. The remaining ₹1.20 Lakh fine was paid, leaving no outstanding fines.
- Value
- ₹0.01 Cr
PC Jeweller Legal & Regulatory
SEBI issued administrative warning letters to PC Jeweller's promoter MD and Company Secretary. The warnings concern failure to maintain a structured digital database for a quarterly business update.